Numerous epigenetic modifications have been identified and correlated with transcriptionally active euchromatin or repressed heterochromatin and many enzymes responsible for the addition and removal of these marks have been characterized. However, less is known regarding how these enzymes are regulated and targeted to appropriate genomic locations. Mammalian CXXC finger protein 1 is an epigenetic regulator that was originally identified as a protein that binds specifically to any DNA sequence containing an unmethylated CpG dinucleotide. Mouse embryos lacking CXXC finger protein 1 die prior to gastrulation, and embryonic stem cells lacking CXXC finger protein 1 are viable but are unable to achieve cellular differentiation and lineage commitment. CXXC finger protein 1 is a regulator of both cytosine and histone methylation. It physically interacts with DNA methyltransferase 1 and facilitates maintenance cytosine methylation. Rescue studies reveal that CXXC finger protein 1 contains redundant functional domains that are sufficient to support cellular differentiation and proper levels of cytosine methylation. CXXC finger protein 1 is also a component of the Setd1 histone H3-Lys4 methyltransferase complexes and functions to target these enzymes to unmethylated CpG islands. Depletion of CXXC finger protein 1 leads to loss of histone H3-Lys4 tri-methylation at CpG islands and inappropriate drifting of this euchromatin mark into areas of heterochromatin. Thus, one function of CXXC finger protein 1 is to serve as an effector protein that interprets cytosine methylation patterns and facilitates crosstalk with histone-modifying enzymes.
Introduction
Epigenetics refers to heritable patterns of gene expression that occur in the absence of altered DNA sequence. This concept is illustrated by a variety of phenomena, including X-chromosome inactivation, in which one X chromosome in each cell of a developing female blastocyst becomes irreversibly inactivated; genomic imprinting, in which maternally and paternally derived alleles of a gene are differentially expressed; and the observation that diverse tissues express distinct sets of genes to permit unique functional properties, yet each (with rare exceptions) carries identical genetic information (1) (2) (3) (4) .
Epigenetic information is largely encoded within chromatin structure. A major class of epigenetic modifications is post-translational modification of histones. Dozens of distinct covalent modifications at specific amino acid residues have been identified, including acetylation, methylation, phosphorylation, and sumoylation (2, 5, 6) . Many of these modifications are tightly correlated with either transcriptionally active euchromatin or transcriptionally silenced heterochromatin. Relatively subtle changes of covalent modifications can result in major changes in chromatin structure. For example, trimethylation at the lysine 4 position of histone H3 is associated with transcriptionally active euchromatin (peaking at promoter sequences), whereas methylation of the lysine 9 position of histone H3 is correlated with transcriptionally repressed heterochromatin. The histone code hypothesis predicts that specific covalent modifications of chromatin (or combinations of modifications) serve as binding sites for effector proteins (also referred to as 'reader' proteins) that modulate gene expression (7) .
A second major class of epigenetic modification is cytosine methylation, which usually occurs in the context of CpG dinucleotides, and is strongly associated with gene repression (8) . DNA methyltransferase (Dnmt) enzymes are responsible for adding a methyl group to form 5-methylcytosine. Dnmt1 is the major maintenance methyltransferase, which preferentially acts on hemimethylated DNA, the immediate product of DNA replication (9) . Dnmt3A and Dnmt3B are de novo methyltransferases that are responsible for establishing cytosine methylation patterns during early development (10) . Approximately 75% of CpG dinucleotides in the human genome are methylated, most of which reside within repetitive DNA elements. The CpG dinucleotide is under-represented in mammalian genomes (;10% of the expected frequency), with the exception of CpG islands, in which clusters of unmethylated CpG dinucleotides are found at the expected frequency near the promoters of ;50% of genes (11) (12) (13) . This unusual dinucleotide distribution appears to be a consequence of DNA repair efficiency following spontaneous cytosine deamination. Cytosine deamination produces uracil, which is efficiently recognized as a site of DNA dam-age by the uracil glycosidase repair enzyme, leading to the subsequent restoration of the cytosine nucleotide. However, deamination of 5-methylcytosine produces thymine, which is repaired at a lower efficiency. Thus, inefficient repair represents a mutagenic pressure that resulted in the loss of most methylated CpG dinucleotides over evolutionary time. The exception to this is CpG islands, which are generally unmethylated and therefore not subject to this mutagenic pressure.
Lower eukaryotes, such as yeast and worms, do not utilize cytosine methylation as an epigenetic regulatory mechanism. However, this machinery is critical for the development of mammals, because ablation of any of the DNMT genes in mice is lethal (10, 14) . Furthermore, mutations in Dnmt3B or the methyl-CpG binding protein MeCP2 lead to immunodeficiency, centromere instability, and facial anomaly syndrome, or the progressive neurogenerative disorder Rett syndrome, respectively (15) (16) (17) (18) (19) . Alterations in cytosine methylation patterns are also frequently observed in cancer (20) (21) (22) (23) . Tumor cells typically carry a globally hypomethylation genome. Paradoxically, these cells also often exhibit hypermethylation of tumor suppressor gene promoters, leading to gene repression. Re-expression of these genes following treatment with Dnmt inhibitors can slow tumor growth, and pharmacological modulators of epigenetic enzymes are being tested as therapeutic agents (24) (25) (26) (27) (28) (29) (30) .
The orderly restriction of lineage potential during development is associated with chromatin remodeling and a progressive accumulation of heterochromatin and restriction of gene expression (31) (32) (33) (34) (35) (36) . Stem cells carry a relatively open chromatin structure, including a novel bivalent chromatin signature found at many critical developmental control genes characterized by the co-existence of euchromatic (histone H3-Lys4 trimethylation) and heterochromatic (histone H3-Lys 27 tri-methylation) epigenetic marks (37) . Bivalent chromatin is abundant in stem cells but is lost upon cellular differentiation (38) . Another feature of stem cell epigenetics is the prevalence of non-CpG cytosine methylation, which is lost upon cellular differentiation and is reacquired upon production of induced pluripotent stem (iPS) cells (39, 40) . It is now clear that resetting to a stem cell chromatin state is necessary for successful nuclear reprogramming during iPS cell production (41) (42) (43) , and the efficiency of iPS cell generation can be increased by modulating the epigenetic machinery (44) (45) (46) (47) .
How the myriad of identified epigenetic modifications influence one another to coordinate appropriate chromatin structure and gene expression is a major area of investigation. It is clear that crosstalk occurs between the two major epigenetic arms (cytosine methylation and the histone code), as well as between distinct histone modifications (48) (49) (50) . For example, sites of cytosine methylation serve as binding sites for methyl-CpG binding proteins such as MeCP2 and Mbd1, which then recruit histone modifying enzymes such as histone deacetylase enzymes to remodel the local histone code and facilitate heterochromatin formation. Furthermore, Dnmt proteins associate with histone deacetylase complexes (51) (52) (53) ; cytosine methylation in Neurospora is dependent on methylation of histone H3; inhibition of histone deacetylase activity by trichostatin A results in a loss of cytosine methylation (54) (55) (56) ; disruption of the Suv39h1 histone H3-Lys9 methyltransferase gene leads to altered localization of Dnmt3b and decreased cytosine methylation at pericentric satellite repeats (57) ; loss of Dnmt1 leads to perturbations in the histone code consistent with reduced heterochromatin (58) ; methylation of histone H4-Arg3 recruits Dnmt3A (59); and monoubiquitination of histone H2B is required for histone H34-Lys4 methylation (60) (61) (62) . Thus, DNA methylation and chromatin condensation are highly integrated and mutually reinforcing mechanisms that establish and maintain heterochromatin, thus providing a unifying framework for the control of chromatin structure and gene regulation (63) .
Mammals utilize an exquisitely intricate complement of epigenetic regulatory mechanisms to control chromatin structure and gene expression during development. For example, yeast cells contain a single histone H3-Lys4 methyltransferase complex (Set1/COMPASS). However, human cells express numerous distinct histone H3-Lys4 methyltransferases, including Setd1A, Setd1B, Smyd3, Mll1, Mll2, Mll3, Mll4, and Set9 (64) (65) (66) (67) (68) (69) (70) (71) . Although generally widely expressed, these mammalian methyltransferases provide non-redundant functions, as loss of a single member of the family can lead to disease or death. For example, chromosomal translocations involving the gene encoding the Mll1 histone H3-Lys4 methyltransferase are frequently found in leukemia (72) (73) (74) (75) (76) (77) ; genetic disruption of the MLL1 or MLL2 genes leads to embryonic lethality in mice (78, 79) ; and depletion of the Smyd3 histone H3-Lys4 methyltransferase by short interfering RNA (siRNA) treatment leads to suppression of cell growth (65) . It is likely that non-redundant function of each histone H3-Lys4 methyltransferase is a result of distinct target gene specificity, but the nature of these gene targets and the mechanisms utilized to achieve unique subnuclear targeting of each methyltransferase are largely unknown.
Over the past 15 years, a multitude of epigenetic marks have been identified and correlated with active or inactive chromatin, and numerous enzymes that add or remove these marks have been identified. However, relatively little is currently known regarding the regulation and genomic targeting of these enzymes.
Cloning and characterization of Cfp1
Given the precedence of methyl-CpG binding proteins that serve as readers or effectors of cytosine methylation patterns, studies were undertaken to determine whether a complementary set of effectors exist that are specific for unmethylated CpG dinucleotides, such as would be found at typical CpG islands. Ligand screening of an expression library with a double-stranded oligonucleotide probe containing an unmethylated CpG dinucleotide resulted in the isolation of cDNAs encoding human CXXC finger protein 1 (Cfp1) (80) . This widely expressed protein is encoded by the CXXC1 gene and exhibits a binding specificity for unmethylated DNA, as methylation of CpG dinucleotide(s) present within a DNAbinding site ablates Cfp1-binding affinity (80-82). Serial selection and amplification of Cfp1-binding sites from a pool of random double-strand oligonucleotide sequences reveals that Cfp1 binds to any DNA sequence containing an unmethylated CpG dinucleotide, although greater affinity is exhibited for sequences that contain adenine or cytosine at the two flanking positions (82) . The DNA-binding activity of Cfp1 is contributed by the CXXC domain (Figure 1 ), which is also found in several other proteins involved in the recognition or establishment of cytosine methylation, including Mbd1, Dnmt1, and Mll1. Cfp1 also contains two plant homeodomains, which are found in several dozen chromatin-associated proteins and are thought to serve as protein/protein interaction modules (83) .
Consistent with binding affinity for unmethylated DNA, Cfp1 exhibits transcriptional activation activity in cotransfection assays, which depends on the presence of a CpG dinucleotide within the promoter of the reporter gene construct (80) . Confocal microscopy reveals that Cfp1 forms euchromatin nuclear speckles, and serial extraction of nuclear extracts indicates that Cfp1 associates strongly with the nuclear matrix (84) . Examination of various truncated forms of Cfp1 indicates that the central portion of this protein (including the acidic, basic, and coiled-coil domains) is required to direct speckling and matrix association, and that this subnuclear distribution is required for transcriptional transactivation activity (84) .
Function of Cfp1 in vertebrate development
Homologous recombination in murine embryonic stem (ES) cells was performed to ablate the CXXC1 gene. ES cells heterozygous for the disrupted CXXC1 allele were injected into blastocysts to generate chimeric mice. Following germline transmission of the disrupted allele, heterozygous mice were bred to assess Cfp1 function during mammalian development. Heterozygous mice express approximately 50% of wild-type levels of Cfp1 and appear normal, but no viable mice were recovered that lack Cfp1 expression (85) . Examination of embryos at various stages of gestation revealed that loss of Cfp1 leads to a peri-implantation death (E4.5-5.5). Blastocysts lacking a CXXC1 gene appear normal and implant in the uterine wall, but these embryos fail to gastrulate. Thus, Cfp1 is required for early mammalian embryogenesis.
Additional experimental approaches demonstrate a role for Cfp1 during later developmental stages. Injection of antisense morpholino oligonucleotides into two-cell zebrafish embryos to deplete Cfp1 leads to a variety of developmental defects, including cardiac edema, runting, incomplete vasculature formation, a failure of primitive hematopoiesis, elevated levels of apoptosis, and death (86) . The specificity of this phenotype was established by repeating the study with a second independent antisense oligonucleotide sequence. Furthermore, the phenotype was rescued by co-injection of mRNA encoding murine Cfp1. Similarly, depletion of Cfp1 using short hairpin RNA leads to cell death in human leukemia cell lines (87) .
Cfp1 is an epigenetic regulator: cytosine methylation
Given the binding affinity of Cfp1 for unmethylated CpG dinucleotides, additional studies were conducted to assess the epigenome in cells lacking Cp1. ES cell lines lacking Cfp1 were derived from blastocysts resulting from breeding between mice heterozygous for the deleted CXXC1 allele. The successful isolation and propagation of Cfp1-deficient ES cell lines demonstrates that Cfp1 is not essential for stem cell viability (88) . This finding also suggests that the timing of death for murine embryos lacking a CXXC1 gene is due to a requirement for Cfp1 during specific developmental stages (e.g., gastrulation), rather than the time at which maternally derived Cfp1 protein is depleted. Importantly, the isolation of ES cells lacking Cfp1 provides a convenient reagent with which to probe the molecular function(s) of Cfp1.
The status of cytosine methylation in ES cells lacking Cp1 was assessed by several methods, including: (i) isoschizomer Southern blot analysis, in which the presence of cytosine methylation at a specific gene locus can be determined using a methyl-sensitive restriction enzyme; (ii) thin layer chromatographic measurement of global 5-methylcytosine levels; and (iii) methyl acceptance assay, in which the ability of a genomic DNA sample to accept methyl groups in an in vitro assay is inversely proportional to the degree of global genomic cytosine methylation present in the sample. All of these approaches indicate that ES cells lacking Cfp1 exhibit a 60-70% decline in genomic cytosine methylation levels (88) . Cytosine methylation deficiency was observed at all genomic loci analyzed, including repetitive DNA elements, single copy genes, and imprinted genes. A similar deficit of global cytosine methylation was observed in zebrafish embryos following treatment with Cfp1 antisense oligonucleotides (86) . Remarkably, the cytosine methylation deficiency observed in CXXC1-null murine ES cells is rescued upon introduction of a Cfp1 expression vector into these cells. Even differential methylation at the paternally imprinted H19 locus was rescued by Cfp1 (88) . Failure to rescue was only observed at the insulin-like growth factor 2 receptor locus, presumably because male ES cells are unable to regenerate a maternal imprint mark. The ability of these cells to restore proper patterns of cytosine methylation following reexpression of Cfp1 illustrates the robust plasticity of this epigenetic modification and suggests that residual epigenetic modifications that persist following loss of Cfp1 provide sufficient information for re-establishment of appropriate cytosine methylation patterns upon restoration of the appropriate regulatory apparatus.
Analysis of cellular extracts reveals that cells lacking Cfp1 exhibit reduced Dnmt activity (88) . These cells exhibit approximately a 60% decline of methyltransferase activity when a hemimethylated oligonucleotide substrate is utilized, which corresponds to the preferred target for the maintenance Dnmt1 enzyme. In contrast, methyltransferase activity towards an unmethylated DNA substrate is normal, suggesting that de novo methyltransferase activity is unaffected by loss of Cfp1. This conclusion is further supported by the finding that ES cells lacking Cfp1 exhibit normal kinetics for the acquisition of de novo cytosine methylation of a transduced provirus (88) . However, the provirus fails to become progressively more heavily methylated over time, which is consistent with a deficiency in maintenance Dnmt activity. Indeed, an indistinguishable pattern of provirus methylation was previously observed when a similar study was performed using ES cells lacking the DNMT1 gene (14) . Cfp1 physically interacts with Dnmt1 and CXXC1-null ES cells contain reduced levels of Dnmt1 protein (89, 90) . However, Cfp1-deficient ES cells express elevated levels of Dnmt1 transcript. Instead, reduced steady-state levels of Dnmt1 in these cells are a consequence of reduced efficiency of Dnmt1 translation and reduced Dnmt1 protein half-life (90) .
ES cells lacking Cfp1, although viable, are unable to achieve cellular differentiation in vitro (88) . Upon induction of differentiation by removal of leukemia inhibitory factor from the growth medium, these cells fail to downregulate stem cell markers such as alkaline phosphatase and Oct4 and fail to induce a variety of lineage-restricted markers such as brachyury (mesoderm), Gata4 (endoderm), c-fms (myeloid), or b-MHC (cardiac). This is consistent with the behavior of Cfp1-null blastocysts, which are unable to gastrulate, and suggests a model in which Cfp1 is required for the remodeling of chromatin structure that is necessary for stem cell differentiation. Importantly, in vitro differentiation capacity is restored to these cells following introduction of a Cfp1 expression vector (88) .
CXXC1-null ES cells also exhibit hypersensitivity to DNA-damaging agents such as ionizing radiation, cisplatin, etoposide, hydrogen peroxide, methylmethanesulfonate, and temozolomide (91) . However, these cells exhibit normal sensitivity to non-genotoxic agents such as methotrexate and paclitaxel. Cfp1-null ES cells also exhibit approximately a 50% decline in the level and enzymatic activity of the apurunic/apyrimidinic endonuclease (Ape) DNA repair enzyme. Whether the observed hypersensitivity to DNA-damaging agents is due to increased DNA accessibility as a consequence of relaxed chromatin structure (i.e., reduced levels of cytosine methylation) or reduced efficiency of the repair of such lesions, or both, remains to be determined. Normal levels of Ape expression and sensitivity to DNA-damaging agents are restored following rescue of CXXC1-null ES cells with the Cfp1 expression vector (91).
Taken together, these findings establish Cfp1 as a critical regulator of maintenance DNA methylation, chromatin structure, stem cell function, and embryonic development.
Cfp1 is an epigenetic regulator: histone methylation
Although the decline in cytosine methylation in the absence of Cfp1 is dramatic, several lines of evidence suggest that Cfp1 serves additional functions. For example, mouse embryos lacking Dnmt1 die later in gestation (around E9.5-10.5) compared to CXXC1-null embryos (E4.5-5.5), despite suffering from a more severe loss of cytosine methylation (14, 85) . In addition, Cfp1 homologs are found in lower eukaryotes such as yeast and worms that lack cytosine methylation. Interestingly, the Cfp1 homologs found in these organisms lack the CXXC DNA-binding domain, suggesting that Cfp1 performs an ancestral function in these organisms, and acquired DNA-binding activity in higher eukaryotes that utilize cytosine methylation as an epigenetic regulatory mechanism.
Sucrose gradient equilibrium centrifugation revealed that endogenous Cfp1 associates with a complex of ;450 kDa (67) . Co-immunoprecipitation studies were performed to gain additional insight into the molecular basis of Cfp1 function. Cfp1 was found to interact with several proteins that represent the mammalian homologs of the yeast Set1/COM-PASS histone H3-Lys4 methyltransferase complex (67) . This includes Setd1A, Ash2L, Rbbp5, Wdr5, and Wdr82. As mentioned above, mammalian cells express numerous distinct histone H3-Lys4 methyltransferase complexes. Further studies revealed that Cfp1 additionally interacts with Setd1B, but not with the Mll members of the histone H3-Lys4 methyltransferase family (68) . It is the Setd1 enzymes that appear to be responsible for the bulk of histone H3-Lys4 methylation in mammalian cells, because siRNA-mediated depletion of either Setd1A or Cfp1 leads to dramatic global reduction in histone H3-Lys4 tri-methylation (92, 93) .
Examination of histone methylation patterns reveals that ES cells lacking Cfp1 contain elevated levels of histone H3-Lys4 methylation (the product of the Set1-catalyzed reaction) and decreased levels of histone H3-Lys9 methylation (67) . This is consistent with reduced levels of cytosine methylation in these cells and indicates reduced levels of heterochromatin. This result also suggests that one function of Cfp1 is to inhibit or restrict the activity of the Setd1 histone H3-Lys4 methyltransferase complexes. Data in support of this idea is provided by confocal microscopy examination of the subnuclear distribution of Setd1A (94) . In wild-type ES cells, the Setd1A protein is nearly exclusively localized to 49,6-diaminidino-2-phenylindone (DAPI)-dim areas of euchromatin. However, in ES cells lacking Cfp1 approximately 25% of the Setd1A protein inappropriately colocalizes with DAPI-bright areas of heterochromatin (Figure 2) . Restriction of Setd1A to euchromatin domains is restored following introduction of a Cfp1 expression vector into the knockout ES cell line. Similar results were obtained when the subnu- (A) The CXXC (DNA-binding) and SID (Setd1-interaction) domains function to tether the Setd1 complex at unmethylated CpG islands, resulting in the acquisition of histone H3-Lys4 trimethylation (H3K4me3) at adjacent nucleosomes (blue circles). CG indicates CpG dinucleotides. (B) In the absence of Cfp1, the Set1d1 complexes are no longer restricted to CpG islands, leading to the loss of histone H3-Lys4 trimethylation at these sites and to the inappropriate drifting of this mark into areas of heterochromatin that contain 5-methylcytosine (5mc).
clear distribution of histone H3-Lys4 tri-methylation, the product of the Setd1A-catalyzed reaction, was analyzed (94) .
In further support for this model, a recent report from the Bird group demonstrated that Cfp1 is found at ;80% of CpG islands and that siRNA-mediated depletion of Cfp1 results in the loss of Set1A occupancy and a consequent reduction of histone H3-Lys4 trimethylation at these sites (92) . Taken together, these data suggest a model in which Cfp1 functions as a reader of cytosine methylation patterns and functions to tether the Setd1 histone H3-Lys4 methyltransferase complexes to unmethylated CpG islands, thus providing crosstalk between patterns of cytosine methylation and the histone code (Figure 3) . Because of the predominance of heterochromatin in cells, this model explains the apparent paradox of reduced histone H3-Lys4 methylation at CpG islands following Cfp1 depletion, while at the same time global levels of this modification are elevated.
Structure/function studies of Cfp1
The ability to rescue various aspects of the CXXC1-null ES cell phenotype by expression of full-length Cfp1 provides an attractive system with which to probe structure/function relationships of Cfp1. Functional domains of Cfp1 that are necessary and/or sufficient to support rescue activity were identified following introduction of various truncated and/or mutated versions of Cfp1 cDNA into knockout ES cells. Surprisingly, these studies revealed that Cfp1 contains redundant functional domains (91, 95) . Expression in CXXC1-null ES cells of either the amino terminal half (aa 1-367) or carboxyl terminal half (aa 361-656) of Cfp1 is sufficient to rescue the defects observed in cytosine methylation, hypersensitivity to DNA-damaging agents, and in vitro differentiation capacity. Point mutations within Cfp1 functional domains were analyzed to further probe the requirements for Cfp1 rescue activity. A point mutation within the CXXC domain (C169A) ablates Cfp1 DNA-binding activity (82) , and a point mutation within the SID domain (C375A) ablates the interaction between Cfp1 and the Set1 enzymes (89) . Introduction of either of these mutations into the full-length Cfp1 cDNA does not affect rescue activity, demonstrating that neither DNA-binding activity nor interaction with the Set1 complexes is required for rescue activity. However, ablation of DNA-binding activity within the 1-367 aa Cfp1 fragment or ablation of Set1 interaction within the 361-656 aa Cfp1 fragment eliminates rescue activity. Similarly, introduction of both point mutations into the full-length Cfp1 cDNA also ablates rescue activity. Thus, retention of either DNA-binding activity or interaction with the Set1 complexes is required for Cfp1 function in these rescue assays.
A prediction of the model that Cfp1 tethers Sed1 complexes to unmethylated CpG islands is that both the CXXC and SID domains of Cfp1 should be required to permit appropriate targeting of the Setd1 protein to euchromatic CpG islands. This was confirmed using confocal microscopy to determine what Cfp1 domains are required to rescue normal subnuclear distribution following transfection into CXXC1-null ES cells (94) . In contrast to the rescue of cytosine methylation, in vitro differentiation, and hypersensitivity to DNA-damaging agents, proper subnuclear distribution of Setd1A and histone H3-Lys4 tri-methylation requires both the DNA-binding and Setd1-interaction domains of Cfp1. This finding reveals distinct functional requirements for rescue of distinct aspects of the CXXC1-null ES cell phenotypes and reveals that proper euchromatic targeting of Setd1A is not required to support proper patterns of cytosine methylation and in vitro differentiation.
Genomic targeting of Setd1 histone H3-Lys4 methyltransferase complexes
The complexity of histone H3-Lys4 methyltransferases present in mammalian cells presumably reflects the requirement for elaborate control of chromatin structure needed for execution of complex developmental programs. The fact that each methyltransferase contributes non-redundant function is illustrated by the severe developmental aberrations observed upon misregulation of a single family member. For example, ablation of the Mll1 gene leads to embryonic death in mice, and chromosomal translocations of this gene are commonly found in human leukemia. Relatively little is known about how each member of the histone H3-Lys4 methyltransferase family is targeted to appropriate genomic sites for action. The data described above demonstrate that one function of Cfp1 is to tether the Setd1A complex to unmethylated CpG islands. However, as described below, genomic targeting of Setd1 complexes is complex, and Cfp1 cannot be the primary determinant for the genomic targeting of the Setd1 complexes.
Several components of the mammalian histone H3-Lys4 methyltransferase complexes have been implicated in genomic targeting. In addition to the previously described role of Cfp1, the yeast homolog (Spp1) has been demonstrated to bind to sites of histone H3-Lys4 methylation (96) and to the carboxyl-tail of histone H2B (97) . Whether these histonebinding properties have been conserved in mammalian Cfp1 remains to be determined. In addition, Wdr5 is a Wd40 domain-containing subunit that is a member of all complexes of this methyltransferase family and binds to the histone H3-Lys4 residue (98) (99) (100) (101) . Wdr82, another Wd40-containing protein, directly interacts with the amino terminal RNA recognition domain within the Setd1A and Setd1B enzymes, and also interacts with RNA polymerase II (pol II) molecules containing Ser5-phosphorylated C-terminal repeats (102) . This form of pol II is characteristic of initiating pol II found near promoters (103) . Thus, the action of Wdr82 tethers the Setd1 methyltransferases to transcription start sites, consistent with a peak of histone H3-Lys4 trimethylation that is observed at these genomic sites. Hence, multiple protein/protein interactions appear to contribute to the proper genomic targeting of mammalian histone H3-Lys4 methyltransferases.
Perhaps the most dramatic example of the complexity of histone methyltransferase targeting is revealed by examination of the Setd1A and Setd1B complexes. The composition of these complexes is identical, except for the identity of the enzymatically active (Setd1) component. Despite this similarity, confocal microscopy analysis of the subnuclear distribution of these factors reveals that they exhibit nearly non-overlapping localization to euchromatic domains ( Figure  4 ) (68) . Given that all of the putative targeting molecules described above are shared by the Setd1A and Setd1B complexes, this observation indicates that yet additional targeting signals are contributed by other molecules that interact differentially between the Setd1A and Setd1B proteins. One candidate that could contribute this activity is Hcf1, which has been implicated in targeting of the Setd1A complex to the herpesvirus immediate early promoters (104) .
Outlook
Research to date has revealed Cfp1 to be an essential regulator of epigenetic marks such as cytosine methylation and histone methylation, and to be essential for embryonic vertebrate development. Given its direct intersection with and regulation of Dnmt1 and the Setd1 histone H3-Lys4 methyltransferases, a better understanding of Cfp1 function could provide important information regarding crosstalk and integration between these two epigenetic marks. Recent developments in chromatin immunoprecipitation and high-throughput sequencing makes feasible a full analysis of the altered epigenome in ES cells lacking Cfp1 (and following rescue), which should reveal new insights into the genomic targeting of epigenetic modifying enzymes. Additional studies are needed to develop a comprehensive understanding of how the redundant functional domains of Cfp1 support its pleiotropic functions. Furthermore, development of conditional knockout mice will permit analysis of Cfp1 function in adult stem cells (e.g., hematopoietic stem cells) and homeostasis of mature tissues.
Highlights
• Cfp1 binds specifically to DNA containing unmethylated CpG dinucleotides.
• Cfp1 is required for early mammalian embryogenesis.
• Murine ES cells lacking Cfp1 are viable, but carry a perturbed epigenome and are unable to achieve cellular differentiation.
• Murine ES cells lacking Cfp1 are hypersensitive to DNAdamaging agents.
• Cfp1 facilitates maintenance cytosine methylation.
• Cfp1 is a component of the Setd1 histone H3-Lys4 methyltransferase complexes.
• Cfp1 functions to restrict Setd1A to unmethylated CpG islands and is required to target histone H3-Lys4 tri-methylation to these sites.
• Cfp1 contains redundant functional domains that are sufficient to support cytosine methylation and cellular differentiation.
• Cfp1 appears to be necessary for chromatin remodeling that is required for stem cell differentiation.
